A Pharmacokinetic and Safety Study of CSTI-500 in Subjects With Prader-Willi Syndrome
Clinical trial NCT05504395 · COMPLETED
Trial details
- NCT number
- NCT05504395
- Sponsor
- ConSynance Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-14
- Primary completion
- 2023-02-21
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.